Authors


Anneliese LoVullo, MT-BC

Latest:

Exploring Music Therapy

3 music therapists share information on their program and treatments.


Sagnik Bhattacharyya, MBBS, MD, PhD

Latest:

The Impact of Cannabis Use on Medication Adherence: A Particular Focus in Psychosis

What is the effect of cannabis use on adherence to medications in patients with psychosis?


Michael McGuire, PharmD

Latest:

Treating Schizophrenia: Bringing Together Pharmacists and Clinicians for Patient Care

How can psychiatric professionals and pharmacists best work together to improve patient care? One pharmacist shares his thoughts.


Barry Wall, MD

Latest:

Insights From the 2022 AAPL Annual Meeting

The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.


Brianna Sa

Latest:

The Impact of Valproic Acid on Neonatal Outcomes

Research reveals significant risks of neonatal complications linked to in utero valproic acid exposure, emphasizing the need for careful management during pregnancy.


Christine Gould, PhD

Latest:

Recognizing and Addressing Psychiatric Implications of Sleep Disorders

What sleep disorders are common in older adults and what are the associated risk factors and correlates?


Paula Yvette Mendoza, MS4

Latest:

Interpret at Your Own Risk: Medical Students as Ad-Hoc Interpreters and Vicarious Trauma

We must educate and provide resources for medical students and institutions.


Zohaib Iqbal

Latest:

Climate Change and Heat-Related Illness: Opportunities for Prevention in Psychiatric Practice

How can we prevent heat-related illness in patients with psychiatric disorders, who are more vulnerable to heat?


Shuo Chen, JD

Latest:

How Cities Can Boost Brain Capital

In a shock-prone world, city-level thinking is a new approach to optimizing the brain health and brain skills of citizens.


Liana Kathleen Glew, PhD

Latest:

Stitching Time: Women and Fiber Art in Psychiatric History

Sewing, weaving, knitting, crochet, and needlework can all be soothing, expressive, and communal. How did women patients in psychiatric history harness the therapeutic and political potential of fiber art? What can we learn about life in psychiatric institutions from their work?


Joseph Cofrancesco Jr, MD, MPH

Latest:

Honoring a Brother

Joseph Cofrancesco Jr, MD, MPH, remembers his brother who died of complications from COVID-19, intubated, sedated, and alone.


Donald Egan, MD, MPH

Latest:

Adaptive Psychiatry: A Framework for Disability-Inclusive Psychiatric Care

How can psychiatric clinicians ensure their practices are accessible to patients with disabilities?


Kenneth R. Weingardt, PhD

Latest:

Issues in Regulating DTx

We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?


Yurandol Powers Thompson, PhD, LPC, NCC

Latest:

Broaching the Topic of Gratitude

How can you foster gratitude in your patients?


Jorge Claudio Ulnik, MD, PhD

Latest:

Building the Bridge Between Psyche and Soma: 2021 Sigourney Award Winner

Psychoanalysis and dermatology: this Sigourney Award Winner is bridging the 2 specialties.


Eric Drogin, JD, PhD

Latest:

Interpreting Digital Information in Forensic Settings

How can digital therapeutics overcome barriers to psychiatric treatment in forensic settings?


Marlin Mattson, MD

Latest:

Psychiatrists Call for End to Cruel and Harmful Immigration Policy

The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.


Catherine E. Cooke, PharmD, MS

Latest:

REMS for Psychiatric Medications: The Good, the Bad, and the Ugly

Session at the 2023 American Psychiatric Association Annual Meeting shares insights on REMS for psychiatric medications.


Nicholas Distefano, MD

Latest:

The Safety of Psychostimulants or Atomoxetine for Patients With Psychotic Disorders

Evidence indicates that children and adolescents with ADHD have a more than 4-fold increased risk of schizophrenia spectrum and other psychotic disorders in adulthood compared with the general population.


Tracy Hicks, DNP, FNP/PMHNP-BC

Latest:

Long-Acting Injectables and a Team-Driven Approach for Schizophrenia Treatment

How can you best discuss long-acting injectable options with your patients living with schizophrenia?


Catherine W. Striley, PhD, MSW, MPE

Latest:

The ABCs of Vaping

What is vaping and when does it become a problem?


Casey Moffitt

Latest:

Conventional and Integrative Approaches to Treating Anxiety in Pregnancy

Women should be provided with multiple options for treatment if they decide to engage in mental health care during this critical period.


Karandeep Sonu Gaind, MD

Latest:

Self-Identified Palliative Psychiatrists Should Disclose Their Views on Psychiatric Euthanasia

The debate over palliative psychiatry's role in advocating for psychiatric euthanasia continues, raising ethical concerns about mental health care and patient autonomy.


Rachel Waddingham

Latest:

A Dialogue on Psychosis and Trauma

Joining together to discuss psychosis, 3 British experts discuss various ways to respond to and help people who have experienced both trauma and psychosis.


Elda Storck

Latest:

The Expanding Reach of the South African Psychoanalytical Association

Thanks to a recent Sigourney Award, this association is achieving well-deserved recognition.


Aaron Koenig
Aaron Koenig, MD

Latest:

Upcoming Research Related to DLX-001 for Major Depressive Disorder

Want to stay in the loop on the latest novel neuroplastogen for major depressive disorder, DLX-001? Check out this update.


Nancy Byatt, DO, MS, MBA, DFAPA, FACLP

Latest:

The Perinatal Mental Health Crisis

Perinatal mood and anxiety disorders affect 1 in 5 of perinatal individuals who are pregnant or up to 1 year postpartum. Over the past 2 decades, the US has seen an alarming rise in these disorders.


Julia Chianelli

Latest:

Yale School of Medicine Receives $27.7 Million Grant Toward Autism Research

Yale's groundbreaking research aims to revolutionize autism treatment through advanced brain modeling and noninvasive communication methods, enhancing patient outcomes.


David Cates, PhD

Latest:

Vaccine Mandate Exemptions for Anxiety: Ethical and Practical Considerations

Does anxiety justify an exemption from vaccine mandates among health care workers?


Michelle Voegels, PMHNP-BC

Latest:

Patient Case: Impact of ADHD on Quality of Life

Panelists discuss how a patient named Kerstin was diagnosed with attention-deficity/hyperactivity disorder (ADHD) later in life during college when she struggled with organization and scheduling beyond her known dyslexia, leading to successful treatment with various stimulant medications including participation in clinical trials.

© 2025 MJH Life Sciences

All rights reserved.